U.S. stock night market opening fluctuations: Las Vegas Sands fell 10.01% in night trading; USA Rare Earth fell 9.25% in night trading

U.S. Stock Night Market Opening Movements Las Vegas Sands fell 10.01% in the night market. Based on recent key news: On January 29, Las Vegas Sands announced its fourth-quarter performance for last year, with net revenue falling 10.1% year-on-year to $213 million, despite a 16.4% increase in net income. This result led to an 8.59% drop in stock price during after-hours trading. Source: Zhitong Finance On January 29, Sands China reported a 14.2% year-on-year decline in net revenue to $901 million, despite a 5.1% increase in net income. This performance raised market concerns about its Macau business, affecting stock prices. Source: Zhitong Finance On January 29, analysts maintained a "Buy" rating on Las Vegas Sands, but concerns over declining profit margins in its Macau business led to stock price fluctuations. Source: Benzinga Concerns over declining profit margins in Macau business. USA Rare Earth fell 9.25% in the night market. Based on recent key news: On January 26, USA Rare Earth announced it had signed a letter of intent with the U.S. Department of Commerce to secure $1.6 billion in funding, including $1.3 billion in loans and $277 million in federal funds. This move aims to accelerate the development of the domestic rare earth supply chain, boosting stock prices. Source: MarketWatch On January 27, analysts pointed out that USA Rare Earth faces up to 75% equity dilution, which dissatisfied some investors and put pressure on stock prices. Source: MarketWatch On January 28, Canaccord Genuity raised USA Rare Earth's target stock price from $23 to $33, reflecting market optimism about its prospects. Source: MarketWatch The rare earth industry is supported by policies, with significant capital inflow. Top Gainers in the U.S. Stock Night Market Serina Therapeutics rose 28.68% in the night market. Based on recent news: On January 28, Serina Therapeutics announced that its drug SER-252 for the treatment of advanced Parkinson's disease received IND application approval from the FDA. This news significantly boosted market confidence, driving stock prices sharply higher. On January 28, the company released a related announcement through the EDGAR system, further confirming this important progress and enhancing investor confidence. On January 28, the company detailed the commercial potential and associated risks of its drug and vaccine candidates in its annual report. Despite uncertainties, the market remains optimistic about its prospects. The biopharmaceutical industry has performed strongly recently, with clear policy support. Tanzania Royal Exploration rose 16.58% in the night market. Based on recent key news: On January 27, TRX Gold Corporation's analyst rating showed a buy, but the market found five other stocks more attractive, leading to a decrease in investor interest in TRX Gold and fluctuations in its stock price. On January 26, TRX Gold announced the acquisition of the Casa Berardi mine for USD 272 million, which is expected to enhance the company's production capacity and exploration potential, driving the stock price up. On January 28, TRX Gold's high profit margins and internal financing growth attracted market attention, with gold prices reaching record highs, resulting in an increase in its stock price. The gold industry has performed strongly recently, with significant capital inflows. CL Workshop rose 16.08% in after-hours trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation